American Gene Technologies International Inc. (AGT) is a private biotechnology company pursuing cures and treatments for infectious diseases, cancers and monogenic disorders. AGT's programs are designed to: Create immunotherapy for HIV disease with gene modified T cells. AGT is pioneering gene therapy solutions to achieve permanent cures for human diseases, including a possible cure for HIV in clinical trials
Market
Healthcare & Wellness
Coinvestors
10X Venture Partners,National Institutes of Health,U.S. Department of Health and Human Services,Gaingels,10X Capital,Alumni Ventures Group